Related references
Note: Only part of the references are listed.Nanotechnology for delivery of peptide nucleic acids (PNAs)
Anisha Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer
Emiliano Cocco et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
Devansu Tewari et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue
Jennifer K. Saucier-Sawyer et al.
JOURNAL OF DRUG TARGETING (2015)
Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo
Salvatore Lopez et al.
MOLECULAR CANCER THERAPEUTICS (2015)
A sunblock based on bioadhesive nanoparticles
Yang Deng et al.
NATURE MATERIALS (2015)
A holistic approach to targeting disease with polymeric nanoparticles
Christopher J. Cheng et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium
Nicole Ali McNeer et al.
NATURE COMMUNICATIONS (2015)
Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeated-injury model
Qinjie Wu et al.
SCIENTIFIC REPORTS (2015)
Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
Asiri Ediriwickrema et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
Asiri Ediriwickrema et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Multi-layered nanoparticles for combination gene and drug delivery to tumors
Asiri Ediriwickrema et al.
BIOMATERIALS (2014)
The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles
Yang Deng et al.
BIOMATERIALS (2014)
Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo
Salvatore Lopez et al.
GYNECOLOGIC ONCOLOGY (2014)
Phase II trial of patupilone in patients with brain metastases from breast cancer
David M. Peereboom et al.
NEURO-ONCOLOGY (2014)
Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer
Shigenobu Emoto et al.
SURGERY TODAY (2014)
Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model
Ming Yang et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)
Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer
Jonathan D. Black et al.
WOMENS HEALTH (2014)
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone
Dana M. Roque et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Tubulin--III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones
Dana M. Roque et al.
CANCER (2013)
Aldehyde dehydrogenases: From eye crystallins to metabolic disease and cancer stem cells
Vasilis Vasiliou et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer
Karim S. El-Sahwi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer
Nicoletta Colombo et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors
Gaurav Bajaj et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
Stefania Nobili et al.
MEDICINAL RESEARCH REVIEWS (2012)
Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro
Sarah N. Cross et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice
Yongsheng Wang et al.
BMC CANCER (2010)
Higher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro
Daniel Paik et al.
GYNECOLOGIC ONCOLOGY (2010)
Drug Delivery Systems for Intraperitoneal Therapy
Gaurav Bajaj et al.
PHARMACEUTICAL RESEARCH (2010)
Gd-Labeled Microparticles in MRI: In vivo Imaging of Microparticles After Intraperitoneal Injection
Jeremy L. Steinbacher et al.
SMALL (2010)
HIPEC: The complexities of clinical trials
David L. Bartlett
ANNALS OF SURGICAL ONCOLOGY (2008)
Molecular Mechanisms of Patupilone Resistance
Simona Mozzetti et al.
CANCER RESEARCH (2008)
Tumor-Penetrating Microparticles for Intraperitoneal Therapy of Ovarian Cancer
Ze Lu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel
Max Tsai et al.
PHARMACEUTICAL RESEARCH (2007)
A phase lb and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer
Martin Forster et al.
CLINICAL CANCER RESEARCH (2007)
A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer®) in recurrent ovarian cancer:: A Gynecologic Oncology Group study
Deborah K. Armstrong et al.
GYNECOLOGIC ONCOLOGY (2006)
Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
DS Kohane et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2006)
Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health
PJ O'Brien et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo
B Lin et al.
BLOOD (2005)
Epothilones: Mechanism of action and biologic activity
S Goodin et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer
S Greggi et al.
ONCOLOGY (2001)
Share Paper
